Jerry Lee, President/CEO stated, “We are very pleased and fortunate to have Dr. Stearns join our Scientific Advisory Board. His passion for developing a cure for prostate cancer coincides directly with diagnostic tests for prostate health we have planned for our TrueDX™ Platform. We look forward to his involvement with our development activities as we continue to commercialize biomarkers onto our new TrueDX Platform.”
Dr. Stearns added, “The promise of proper medical treatment all starts with proper diagnosis. That’s exactly what they’re doing at True Diagnostics and I’m excited to be a part of helping to shape their direction.”
# # #
About the Company
True Diagnostics, Inc. creates diagnostic solutions for the $18 billion point-of-care IVD market. After 30 years in the global medical diagnostic field, the inventor of the pregnancy test created the TrueDX Platform which can measure the severity of any medical condition (using only a finger prick of blood, small urine or saliva sample, toxins, surface bacteria, and more), provide results in minutes (not days), and is portable. The TrueDX Platform takes point-of-care, point-of-incidence, and remote-of-care applications out of the lab to allow patient treatment to begin immediately. The flexibility of the TrueDX Platform creates unique and powerful opportunities for new diagnostic solutions through its ability to: 1) quickly bring new diagnostic tests to market; and, 2) open new geographic and application markets.
For more information, call 760-683-9158 or go to www.TrueDiagnostics.com
Jerry Lee, President/CEO